Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Chronic Plaque Psoriasis”

168 trials

Showing 20 of 168 results

Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT03025542
What this trial is testing

Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 49
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Not applicableStudy completedNCT00769184
What this trial is testing

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Who this might be right for
Psoriasis
NeoStrata Company, Inc. 15
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Not applicableStudy completedNCT01084668
What this trial is testing

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

Who this might be right for
Psoriasis Chronic
Abbott 46
Testing effectiveness (Phase 2)Study completedNCT03614078
What this trial is testing

PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
PRCL Research Inc. 92
Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598
Post-approval studies (Phase 4)Study completedNCT00658606
What this trial is testing

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Astellas Pharma Inc 98
Testing effectiveness (Phase 2)Study completedNCT03010527
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 217
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Large-scale testing (Phase 3)Study completedNCT05335356
What this trial is testing

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 384
Testing effectiveness (Phase 2)Study completedNCT00646191
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 137
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Post-approval studies (Phase 4)Study completedNCT00249808
What this trial is testing

Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 1,266
Testing effectiveness (Phase 2)Study completedNCT00292396
What this trial is testing

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 180
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation